LabPMM Launches Global KMT2A MRD Testing Service to Support Precision Monitoring and Clinical Development in Acute Leukemia LabPMM®, a global reference laboratory and subsidiary of Invivoscribe®, has announced the worldwide availability of its new KMT2A measurable residual disease (MRD) testing…
Pilatus Biosciences to Present Preclinical Data Highlighting PLT012’s Disease-Modifying Potential in COPD at ERS International Congress 2026 Pilatus Biosciences, a clinical-stage biopharmaceutical company focused on developing innovative metabolic checkpoint immunotherapies for cancer and immune-mediated diseases, has announced that new preclinical…
Rocket Pharmaceuticals Reports Positive Early Safety Update for RP-A501 Phase 2 Trial in Danon Disease Rocket Pharmaceuticals, Inc. has announced encouraging early safety results from the first three patients treated under the modified protocol of its global pivotal Phase 2…
Novo Nordisk Reports Topline Results from Phase 3 ZEUS Trial Evaluating Ziltivekimab for Cardiovascular Risk Reduction Novo Nordisk has announced topline findings from its pivotal Phase 3 ZEUS cardiovascular outcomes trial, providing new insights into the role of interleukin-6 (IL-6)…
PHC Corporation of North America Launches Cell-IQ® CO₂ Incubator Series with Advanced Humidity Control and Contamination Prevention PHC Corporation of North America (PHCNA), a leading provider of PHCbi laboratory equipment and sample preservation technologies across North America and Latin America,…
PVP Labs to Present Taphalgin® Research at 2026 Military Health System Research Symposium, Highlighting a Novel Battlefield Pain Management Approach PVP Labs, a clinical-stage biotechnology company focused on developing innovative peptide-based therapeutics, has announced that new research on its investigational…
Feinstein Institutes Researchers Discover the Brain’s Respiratory Alarm Mechanism Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a previously unknown brain circuit that continuously monitors every breath we take, providing new insights into how humans consciously detect…
PK MED Strengthens Leadership and Scientific Governance to Advance ARTHRELIS and ENGRAFTIS Development Programs PK MED, a French biotechnology company established by healthcare investment firm Truffle Capital, has announced a significant expansion of its corporate governance with the appointment of…
Niagen Bioscience Publishes New Research Linking Niagen® Supplementation to Reduced Biological Aging in Skeletal Muscle Niagen Bioscience, Inc., a global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging research, has announced the publication of a new peer-reviewed study…
Precision BioSciences Strengthens Executive Leadership to Support Clinical Growth and Advance Gene Editing Pipeline Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company focused on developing transformative in vivo gene editing therapies for serious diseases with significant unmet medical…
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Secures Approximately $200 Million to Advance First-in-Class Autoimmune Thyroid Disease Program Yarrow Bioscience, Inc., a clinical-stage biotechnology company dedicated to developing innovative therapies for autoimmune thyroid diseases, has announced the successful completion…
Aptar Pharma’s Nanopharm Facility Earns MHRA GMP Certification, Strengthening Global Support for Inhaled and Nasal Drug Development Aptar Pharma, a global leader in drug delivery systems, dosing technologies, protection solutions, and pharmaceutical development services, has announced that its Nanopharm facility…